Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Palonosetron + Midazolam for PONV
NCT03933605Completed
- Sponsor
- Yeungnam University College of Medicine
- Start
- Jul 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Midazolam + Palonosetron with Palonosetron + Placebo (2 arms). Primary endpoints: Incidence of postoperative nausea and vomiting at 24 hours and Severity of postoperative nausea and vomiting at 24 hours. Started Jul 2017; status: completed.
02
Drugs
midazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03933605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03933605.